People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medcura, Inc. | — | Biotechnology | Series B | $40.9M | $145.0M | 2016 |
| GenrAb, Inc. | — | Other Health Care | Series A | $4.6M | $38.1M | 2022 |
Larry Tiffany at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Larry Tiffany on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rich Vincent | 1 | 3 |
| Richard Vincent | 1 | 2 |
| JIM BUCK | 1 | 2 |
| Matthew Dowling | 1 | 1 |
| Alex Arrow | 1 | 1 |
| Neil Warma | 1 | 1 |
| Nancy Monson | 1 | 1 |
| Doug Kerr | 1 | 1 |
| Benjamin Greenberg | 1 | 1 |
| Abbas Ardehali, M.D. | 1 | 1 |
| Matthew Dowling, Ph.D | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.